CoChat

Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities

Garza, Z.C. Félix, Born, M., Hilbers, P.A.J., van Riel, N.A.W., Liebmann, J. · 2019 · Current Medicinal Chemistry
Cited by 86

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near infrared regions of the visible spectrum. Considerably less effort has been dedicated to the blue, UV-free part of the spectrum. Objective: In this review, we discuss the current advances in the understanding of the molecular photoacceptors, signaling mechanisms, and corresponding therapeutic opportunities of blue light photoreception in non-visual mammalian cells in the context of inflammatory skin conditions. Methods: The literature was scanned for peer-reviewed articles focusing on the molecular mechanisms, cellular effects, and therapeutic applications of blue light. Results: At a molecular level, blue light is absorbed by flavins, porphyrins, nitrosated proteins, and opsins; inducing the generation of ROS, nitric oxide release, and the activation of G protein coupled signaling. Limited and contrasting results have been reported on the cellular effects of blue light induced signaling. Some investigations describe a regulation of proliferation and differentiation or a modulation of inflammatory parameters; others show growth inhibition and apoptosis. Regardless of the elusive underlying mechanism, clinical studies show that blue light is beneficial in the treatment of inflammatory skin conditions. Conclusion: To strengthen the use of blue light for therapeutic purposes, further in depth studies are clearly needed with regard to its underlying molecular and cellular mechanisms, and their translation into clinical applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/0929867324666170727112206

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 111

  1. . Biological effects of polychromatic light. · doi:10.1562/0031-8655(2002)076<0164:beopl>2.0.co;2
  2. van Loveren H. Effects of ultraviolet exposure on the immune system. · DOI · Paper page
  3. Douki T, Ravanat J-L. Oxidatively generated damage to cellular DNA by UVB and UVA radiation. · DOI · Paper page
  4. . Cellular and Molecular Mechanisms of Photobiomodulation (Low-Power Laser Therapy). · doi:10.1109/jstqe.2013.2273411
  5. Ball KA. Therapeutic photobiomodulation: Nitric oxide and a novel function of mitochondrial cytochrome c oxidase.
  6. Wang S, Tsoukas MM. Phototherapy in cosmetic dermatology. · DOI
  7. . For better or for worse, UV in Psoriasis. · DOI
  8. Raone B, Ravaioli GM. Management of atopic dermatitis: safety and efficacy of phototherapy. · DOI
  9. Kumimoto H, Ishizaki K, Sakumi K, Nakabeppu Y, Nishigori C. Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. · DOI
  10. Apetato M. The dark side of the light: Phototherapy adverse effects. · DOI
  11. Pyatibrat LV, Kolyakov SF, Afanasyeva NI. Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. · DOI · Paper page
  12. Dai T, Sharma SK, Huang Y-Y, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. · DOI · Paper page
  13. Gupta A, Murray CK, Vrahas MS, Tegos GP, Hamblin MR. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? · DOI · Paper page
  14. Langer E, Seemann M, Seemann G, Fell I, Saloga J, Grabbe S, von Stebut E. Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis. · DOI · Paper page
  15. Smits T, Frunt MH, van Erp PE, van de Kerkhof PC, Gerritsen RM. Clinical and histological effects of blue light on normal skin. · DOI · Paper page
  16. Lanzafame RJ, Arany PR. Low-level light/laser therapy versus photobiomodulation therapy. · DOI · Paper page
  17. Arany P. Photobiomodulation and implants: Implications for dentistry. · DOI
  18. Lavi R, Shainberg A, Lubart R. Flavins are source of visible-light-induced free radical formation in cells. · DOI · Paper page
  19. . Blue-light photoreceptors: From activation to advanced applications. · doi:10.1039/c2pp25254f
  20. Lambert S, Martino C, Jourdan N, Bouchet P-E, Witczak J, Castello P, El-Esawi M, Corbineau F, d’Harlingue A, Ahmad M. Blue-light dependent reactive oxygen species formation by Arabidopsis cryptochrome may define a novel evolutionarily conserved signaling mechanism. · DOI
  21. Nagata T. Functional properties of opsins and their contribution to light-sensing physiology. · DOI
  22. Freddolino PL, Nash AI, Carroll EC, Schulten K, Gardner KH, Larsen DS. Modulating LOV domain photodynamics with a residue alteration outside the chromophore binding site. · DOI
  23. Klug G. BLUF: a novel FAD-binding domain involved in sensory transduction in microorganisms. · DOI · Paper page
  24. Cashmore AR. HY4 gene of A. thaliana encodes a protein with characteristics of a blue-light photoreceptor. · DOI · Paper page
  25. Hoff WD, Van West M, Kroon AR, Hoffer SM, Vlieg KH, Crielaand W, Van Beeumen JJ, Hellingwerf KJ. The xanthopsins: a new family of eubacterial blue-light photoreceptors. · DOI
  26. Jung KH, Spudich JL. Molecular mechanism of photosignaling by archaeal sensory rhodopsins. · DOI · Paper page
  27. Gärtner W. Old chromophores, new photoactivation paradigms, trendy applications: flavins in blue light-sensing photoreceptors. · DOI
  28. Domratcheva T, Tarutina M, Wu Q, Ko W-H, Shoeman RL, Gomelsky M, Gardner KH, Schlichting I. Structure of a bacterial BLUF photoreceptor: insights into blue light-mediated signal transduction. · DOI · Paper page
  29. Sancar A. Cryptochromes and circadian photoreception in animals. · DOI
  30. . Xie, C.; Gu, Y.; Li, X.; Tong, J. Illumnination from Light-Emitting Diodes (LEDs) Disrupts Pathological Cytokines Expression and Activates Relevant Signal Pathways in Primary Human Retinal Pigment Epithelial Cells. · DOI
  31. . Evolution of phototransduction, vertebrate photoreceptors and retina. · DOI · Paper page
  32. Valtink M, Roehlecke C, Lupp A, de la Vega J, Mehner M, Funk RHW. Blue light stress in retinal neuronal (R28) cells is dependent on wavelength range and irradiance. · DOI
  33. Yamashita T, Imamoto Y, Shichida Y. Photochemical properties of mammalian melanopsin. · DOI · Paper page
  34. Kang SH, Xue T, Zhong H, Liao H-W, Bergles DE, Yau K-W. Photon capture and signalling by melanopsin retinal ganglion cells. · DOI · Paper page
  35. Suschek CV. The role of photolabile dermal nitric oxide derivates in ultraviolet radiation (UVR)-induced cell death. · DOI
  36. Deck A, Volkmar CM, Kirsch M, Liebmann J, Born M, van Abeelen F, van Faassen EE, Kröncke K-D, Windolf J, Suschek CV. Mechanism and biological relevance of blue-light (420-453 nm)-induced nonenzymatic nitric oxide generation from photolabile nitric oxide derivates in human skin and · DOI
  37. Son ED, Jung J-Y, Choi H, Lee TR, Shin DW. Violet light down-regulates the expression of specific differentiation markers through Rhodopsin in normal human epidermal keratinocytes. · DOI
  38. Scurachio RS, Santos WG, Homem-de-Mello P, Skibsted LH. Riboflavin-photosensitized oxidation is enhanced by conjugation in unsaturated lipids. · DOI
  39. Madsen PH, Vandborg PK, Jakobsen LH, Trydal T, Vreman HJ. Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue). · doi:10.1038/pr.2016.115
  40. Wataha JC, Messer RLW, Caughman GB, Yamamoto T, Hsu SD. Blue light differentially alters cellular redox properties. · DOI
  41. Ikeyama K, Denda S, Nakanishi J, Fuziwara S, Aoki H, Denda M. Expressions of rod and cone photoreceptor-like proteins in human epidermis. · DOI
  42. . The chemical and biological versatility of riboflavin. · doi:10.1042/bst0280283 · Paper page
  43. Gardner KH. Tripping the light fantastic: blue-light photoreceptors as examples of environmentally modulated protein-protein interactions. · DOI
  44. Braslavsky SE. Photoinduced electron transfer to triplet flavins. Correlation between the volume change-normalized entropic term and the Marcus reorganization energy. · doi:10.1021/jp0570115
  45. Senda M, Kimura S, Ishida T. Redox control of protein conformation in flavoproteins. · DOI · Paper page
  46. Owen B, Wataha JC, Campo MA, Lange N, Schrenzel J. Intracellular reactive oxygen species in monocytes generated by photosensitive chromophores activated with blue light. · DOI
  47. Shiotsu-Ogura Y, Wada-Takahashi S, Takahashi S-S, Toyama T, Yoshino F. Blue light irradiation-induced oxidative stress ROS generation in rat gingival tissue. · DOI
  48. Schleicher E, Kacprzak S, Bouly J-P, Picot M, Wu W, Berndt A, Wolf E, Bittl R, Ahmad M. Human and Drosophila cryptochromes are light activated by flavin photoreduction in living cells. · DOI · Paper page
  49. Ahmad M. Light-activated cryptochrome reacts with molecular oxygen to form a flavin-superoxide radical pair consistent with magnetoreception. · DOI · Paper page
  50. Friedman H, Savion N, Kotev-Emeth S, Breitbart H, Lubart R. Visible light induces nitric oxide (NO) formation in sperm and endothelial cells. · DOI
  51. Boldyrev AI. Deciphering aromaticity in porphyrinoids via adaptive natural density partitioning. · DOI
  52. Faustino MAF, Neves MGPMS, Cunha Â, Nadais H, Almeida A. Potential Applications of Porphyrins in Photodynamic Inactivation beyond the Medical Scope. J. Photochem. Photobiol. C Photochem.
  53. Viveiros J, Yang C, Ahmadi A, Ganz RA, Tolkoff MJ. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. · doi:10.1128/aac.49.7.2822-2827.2005
  54. McKenzie K, Anderson JG, Gettinby G, MacGregor SJ. 405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection control. · DOI · Paper page
  55. . The opsins. · DOI
  56. Matsuyama T. Evolution of Opsins and Phototransduction. Philos. Trans. R. Soc. B Biol.
  57. Takada E, Nagata T, Tsukamoto H, Terakita A. Homologs of vertebrate Opn3 potentially serve as a light sensor in nonphotoreceptive tissue. · DOI · Paper page
  58. Mori S, Torii M, Wada A, Morishita R, Fukada Y. UV-sensitive photoreceptor protein OPN5 in humans and mice. · DOI · Paper page
  59. Ozdeslik RN, Wicks NL, Najera JA, Oancea E. Opsin expression in human epidermal skin. · DOI · Paper page
  60. Choi MS, Bae I-H, Jung JY, Son ED, Lee TR, Shin DW. Short Wavelength Visible Light Suppresses Innate Immunity-Related Responses by Modulating Protein S-Nitrosylation in Keratinocytes. · DOI
  61. Born M, Kolb-Bachofen V. Blue-light irradiation regulates proliferation and differentiation in human skin cells. · DOI · Paper page
  62. Mittermayr R, Haindl S, Osipov A, Wagner C, Redl H, Kozlov AV. Illumination with blue light reactivates respiratory activity of mitochondria inhibited by nitric oxide, but not by glycerol trinitrate. · DOI
  63. Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. · DOI · Paper page
  64. Wataha JC, Kachi H, Lewis JB, Messer RL, Sano H. Radicals produced by blue-light-resin interactions alter the redox status of THP1 human monocytes. · DOI
  65. Yoshida A, Okada E, Okada Y, Maehata Y, Miyamoto C, Kishimoto S, Otsuka T, Nishimura T, Lee MC. Dental resin curing blue light induced oxidative stress with reactive oxygen species production. · DOI
  66. Yoshino F, Makita T, Maehata Y, Higashi K, Miyamoto C, Wada-Takahashi S, Takahashi SS, Takahashi O, Lee MC. Reactive oxygen species production in mitochondria of human gingival fibroblast induced by blue light irradiation. · DOI
  67. Mavrogonatou E, Eliades T, Papagiannoulis L, Eliades G, Kletsas D. Effect of blue light on the proliferation of human gingival fibroblasts. · doi:10.1016/j.dental.2007.10.006
  68. Demir E, Kauczok J, Fuchs PC, Born M, Suschek CV, Opländer C. Blue light inhibits transforming growth factor-β1-induced myofibroblast differentiation of human dermal fibroblasts. · DOI
  69. Lembo S, Cantelli M, Ciaglia E, Scarpato L, Fabbrocini G, Balato A. The effect of visible blue light on the differentiation of dendritic cells · DOI
  70. Kawashima Y, Kitajima S, Mitsuoka C, Watanabe H. Blue light inhibits the growth of skin tumors in the v-Ha-ras transgenic mouse. · DOI
  71. Lewis JB, Lockwood PE, Hsu S, Messer RL, Rueggeberg FA, Bouillaguet S. Blue light differentially modulates cell survival and growth. · DOI
  72. Shamsi FA, Liang F-Q, Jarrett SG, Davies S, Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. · DOI · Paper page
  73. Lockwood PE, Lewis JB, Rueggeberg FA, Messer RLW. Biological effects of blue light from dental curing units. · DOI
  74. Zhang P, Wang W, Xu Y, Wang M, Chen X, Dong X. Long-term blue light exposure induces RGC-5 cell death : involvement of mitochondria-dependent apoptosis, oxidative stress, and MAPK signaling pathways. · DOI
  75. Hidding S, Werners FB, Born M, Pallua N, Suschek CV. Effects of blue light irradiation on human dermal fibroblasts. · DOI · Paper page
  76. Lewis JB, Lockwood PE, Noda M, Messer RL, Hsu S. Response of THP-1 monocytes to blue light from dental curing lights. · doi:10.1111/j.1365-2842.2007.01806.x
  77. . Nitric oxide and cell proliferation. · DOI · Paper page
  78. Tu S, Akhtar MW, Sunico CR, Okamoto S, Lipton SA. Aberrant protein s-nitrosylation in neurodegenerative diseases. · DOI · Paper page
  79. Rojanasakul Y, Azad N. Nitrosothiol signaling and protein nitrosation in cell death. · DOI
  80. . Apoptotic pathways: Ten minutes to dead. · DOI · Paper page
  81. Na KS, Hwang H, Jeong H-S, Lim S, Sohn M-H, Jeong H-J. Effect of blue light emitting diodes on melanoma cells: involvement of apoptotic signaling. · DOI
  82. Hwang H, Jeong H-S, Kwon J, Kim H-S, Kim M, Lim S, Sohn M-H, Jeong H-J. Blue light emitting diode induces apoptosis in lymphoid cells by stimulating autophagy. · DOI
  83. Bibinov N, Born M, Busse B, Gesche R, Helmke A, Kaemling A, Kolb-Bachofen V, Kovacs R, Kuehn S, Liebmann J, Mertens N, Niemann U, Oplaender C, Porteanu H-E, Scherer J, Suschek C, Vioel W, Wandke D. Biological stimulation of the human skin applying healthpromoting light and plasma sources. · doi:10.1002/ctpp.200910068
  84. Faucher K, Sol V, Durox H, Boulinguez S, Doffoel-Hantz V, Calliste C-A, Cook-Moreau J, Krausz P, Sturtz FG, Bedane C, Jauberteau-Marchan M-O, Ratinaud M-H, Bonnetblanc J-M. Blue light is phototoxic for B16F10 murine melanoma and bovine endothelial cell lines by direct cytocidal effect.
  85. Kawashima Y, Katoh O, Watanabe H. Blue light inhibits the growth of B16 melanoma cells. · DOI
  86. Klapczynski A, Kuch N, Arpino F, Simon-Keller K, De La Torre C, Sticht C, van Abeelen FA, Oversluizen G, Gretz N. Gene expression profiling reveals aryl hydrocarbon receptor as a possible target for photobiomodulation when using blue light. · DOI · Paper page
  87. Yaping E, Geen S, Shalita AR, Lee W-L. Anti-inflammatory properties of narrow-band blue light.
  88. Abel M, Lopez Kostka S, Rudolph B, Becker D, von Stebut E. Blue light irradiation suppresses dendritic cells activation · DOI · Paper page
  89. Ckless K, Korn SH, Vos N, Guala AS, Wouters EFM, van der Vliet A, Janssen-Heininger YMW. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. · DOI · Paper page
  90. Bruch-Gerharz D, Suschek C, Kröncke K-D, Ruzicka T, Kolb-Bachofen V. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. · DOI · Paper page
  91. Pierrard C, Lejeune F, Sok J, Thomas M, Bernerd F. Different oxidative stress response in keratinocytes and fibroblasts of reconstructed skin exposed to non extreme daily-ultraviolet radiation. · DOI · Paper page
  92. Wataha JC, Lewis JB, Tseng WY, Messer RLW, Hsu SD. Blue light generates reactive oxygen species (ROS) differentially in tumor vs. normal epithelial cells. · DOI
  93. Lewis JB, Rotenberg S, Lockwood PE, Messer RL, Noda M, Hsu SD, Sano H, Wataha JC. Intra- and extracellular reactive oxygen species generated by blue light. · DOI
  94. Lewis JB, Lockwood PE, Tseng WY, Messer RL, Hsu SD, Omata Y, Wataha JC. Extracellular environment as one mediator of blue light-induced mitochondrial suppression. · doi:10.1016/j.dental.2005.11.003
  95. . The role of oxygen radicals in human disease, with particular reference to the vascular system.
  96. Godoy JR, Berndt C, Hudemann C, Lillig CH. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. · DOI · Paper page
  97. Hwang JH, Kwon HN, Choi CW, Ko SY, Park WS, Shin SM, Lee M. and efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice. · doi:10.3346/jkms.2005.20.1.61
  98. Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates.
  99. Hanakawa S, Kabashima K. Classification of inflammatory skin diseases: A proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. · DOI
  100. Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. · DOI · Paper page
  101. Di Meglio P, Nestle FO. Psoriasis. · DOI · Paper page
  102. . Atopic dermatitis: Global epidemiology and risk factors. · DOI · Paper page
  103. Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. · DOI · Paper page
  104. Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine.
  105. Medve-Koenigs K, Ruzicka T, Ranft U, Wilkens JH. Ultraviolet-free phototherapy. · DOI
  106. Pfaff SC, Born M, Liebmann J, Merk HF, von Felbert V. Prospective, randomized study on the efficacy and safety of local UV-free blue light treatment of eczema. · DOI
  107. Viau G, Bissonnette R. Repeated exposure to blue light does not improve psoriasis. · DOI
  108. Hoff-Lesch S, Merk HF, von Felbert V. Prospective randomized study on the efficacy of blue light in the treatment of psoriasis vulgaris. · DOI
  109. Otero ME, van Erp PEJ, Gerritsen MJP, van de Kerkhof PCM. Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study. · DOI
  110. Liebmann J, Born M, Merk HF, von Felbert V. Prospective randomized long-term study on the efficacy and safety of UV-free blue light for treating mild psoriasis vulgaris. · DOI
  111. Garcha M, Jagdeo J. Light emitting diode-generated blue light modulates fibrosis characteristics: fibroblast proliferation, migration speed, and reactive oxygen species generation. · DOI

Cited by

See all 86

Metadata

Authors
Garza, Z. C. F., Born, M., Hilbers, P. A. J., van Riel, N. A. W., & Liebmann, J.
Venue
Current Medicinal Chemistry
Published
2019-01-21
Volume
25
Issue
40
Pages
5564-5577
ISSN
0929-8673 (ISSN-L)
OpenAlex
W2740664267
Cited by
86
References
10
FWCI
3.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities. https://app.cochat.ai/papers/10.2174/0929867324666170727112206
The paper
Garza, Z. C. F., Born, M., Hilbers, P. A. J., van Riel, N. A. W., & Liebmann, J. (2019). Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities. Current Medicinal Chemistry. https://doi.org/10.2174/0929867324666170727112206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.